COVID-19 Vaccine Associated with Cutaneous Involvement: Correspondence
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Keywords :
Adverse drug effects, COVID, Vaccine
Citation Information :
Mungmunpuntipantip R, Wiwanitkit V. COVID-19 Vaccine Associated with Cutaneous Involvement: Correspondence. Indian J Crit Care Med 2023; 27 (8):599-599.
Sinha S, Tripathy S. COVID-19 vaccine-associated thrombosis (disseminated intravascular thrombosis) with rare cutaneous involvement. Indian J Crit Care Med 2022;26(8):963–965. DOI: 10.5005/jp-journals-10071-24282.
Kebayoon A, Wiwanitkit V. Dengue after COVID-19 vaccination: Possible and might be missed. Clin Appl Thromb Hemost 2021;27:10760296211047229. DOI: 10.1177/10760296211047229.
Sookaromdee P, Wiwanitkit V. Severe immune thrombocytopenia following COVID-19 vaccination. Am J Emerg Med 2022;58:337. DOI: 10.1016/j.ajem.2022.03.055.
Joob B, Wiwanitkit V. Letter to the editor: Coronavirus Disease 2019 (COVID-19), infectivity, and the incubation period. J Prev Med Public Health 2020;53(2):70. DOI: 10.3961/jpmph.20.065.
